INTEL CORP (INTC) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | INTC | PFE |
|---|---|---|
| Sector | Information Technology | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $52.85B | $62.58B |
| Revenue growth (YoY) | ▼ 0.5% | ▼ 1.6% |
| Net income | $26.00M | $7.81B |
| Gross margin | 34.8% | — |
| Diluted EPS | $-0.06 | $1.36 |
| Insider net (6 mo) | +353.2K sh · 2 sells · 1 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 51 | 44 |
| Institutional value held | $349.26B | $61.93B |
| Next earnings (est.) | Oct 22, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About INTEL CORP (INTC)
Intel Corporation reported 2022 revenue of $63.1 billion, down 20% from 2021, driven by a 23% decline in Client Computing Group (CCG) revenue and a 15% decline in Data Center and AI (DCAI) revenue, partially offset by 11% growth in Network and Edge (NEX) reven
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.